日本新薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2010/11/19 | 1,134 | 1,134 | 1,102 | 1,111 | -23 | -2% | 345,000 |
2010/11/18 | 1,105 | 1,137 | 1,104 | 1,134 | +23 | +2.1% | 224,000 |
2010/11/17 | 1,107 | 1,114 | 1,102 | 1,111 | +4 | +0.4% | 93,000 |
2010/11/16 | 1,127 | 1,129 | 1,102 | 1,107 | -19 | -1.7% | 230,000 |
2010/11/15 | 1,134 | 1,135 | 1,121 | 1,126 | +4 | +0.4% | 140,000 |
2010/11/12 | 1,135 | 1,140 | 1,121 | 1,122 | -9 | -0.8% | 212,000 |
2010/11/11 | 1,153 | 1,153 | 1,115 | 1,131 | -13 | -1.1% | 269,000 |
2010/11/10 | 1,153 | 1,161 | 1,135 | 1,144 | +4 | +0.4% | 170,000 |
2010/11/09 | 1,135 | 1,150 | 1,127 | 1,140 | +6 | +0.5% | 218,000 |
2010/11/08 | 1,127 | 1,137 | 1,115 | 1,134 | +11 | +1% | 330,000 |
2010/11/05 | 1,166 | 1,171 | 1,122 | 1,123 | -23 | -2% | 331,000 |
2010/11/04 | 1,128 | 1,155 | 1,112 | 1,146 | +19 | +1.7% | 636,000 |
2010/11/02 | 1,123 | 1,134 | 1,111 | 1,127 | -2 | -0.2% | 233,000 |
2010/11/01 | 1,137 | 1,144 | 1,124 | 1,129 | -11 | -1% | 175,000 |
2010/10/29 | 1,137 | 1,148 | 1,113 | 1,140 | -5 | -0.4% | 314,000 |
2010/10/28 | 1,152 | 1,167 | 1,133 | 1,145 | -19 | -1.6% | 321,000 |
2010/10/27 | 1,171 | 1,176 | 1,159 | 1,164 | -16 | -1.4% | 267,000 |
2010/10/26 | 1,145 | 1,185 | 1,145 | 1,180 | ±0 | ±0% | 277,000 |
2010/10/25 | 1,187 | 1,194 | 1,176 | 1,180 | -17 | -1.4% | 123,000 |
2010/10/22 | 1,181 | 1,199 | 1,180 | 1,197 | +11 | +0.9% | 155,000 |
2010/10/21 | 1,186 | 1,192 | 1,175 | 1,186 | -13 | -1.1% | 248,000 |
2010/10/20 | 1,204 | 1,204 | 1,177 | 1,199 | -8 | -0.7% | 175,000 |
2010/10/19 | 1,198 | 1,210 | 1,195 | 1,207 | +10 | +0.8% | 179,000 |
2010/10/18 | 1,185 | 1,197 | 1,184 | 1,197 | +20 | +1.7% | 123,000 |
2010/10/15 | 1,194 | 1,194 | 1,176 | 1,177 | -16 | -1.3% | 196,000 |
2010/10/14 | 1,197 | 1,207 | 1,190 | 1,193 | ±0 | ±0% | 303,000 |
2010/10/13 | 1,172 | 1,195 | 1,168 | 1,193 | +36 | +3.1% | 353,000 |
2010/10/12 | 1,189 | 1,198 | 1,157 | 1,157 | -31 | -2.6% | 273,000 |
2010/10/08 | 1,188 | 1,196 | 1,185 | 1,188 | -12 | -1% | 371,000 |
2010/10/07 | 1,180 | 1,204 | 1,178 | 1,200 | +15 | +1.3% | 239,000 |
2010/10/06 | 1,187 | 1,189 | 1,175 | 1,185 | -5 | -0.4% | 365,000 |
2010/10/05 | 1,192 | 1,197 | 1,175 | 1,190 | -11 | -0.9% | 362,000 |
2010/10/04 | 1,199 | 1,207 | 1,190 | 1,201 | +23 | +2% | 370,000 |
2010/10/01 | 1,161 | 1,193 | 1,161 | 1,178 | +18 | +1.6% | 439,000 |
2010/09/30 | 1,145 | 1,164 | 1,132 | 1,160 | +16 | +1.4% | 305,000 |
2010/09/29 | 1,127 | 1,151 | 1,123 | 1,144 | +10 | +0.9% | 279,000 |
2010/09/28 | 1,103 | 1,152 | 1,103 | 1,134 | +30 | +2.7% | 400,000 |
2010/09/27 | 1,096 | 1,117 | 1,096 | 1,104 | +8 | +0.7% | 111,000 |
2010/09/24 | 1,100 | 1,100 | 1,087 | 1,096 | -10 | -0.9% | 195,000 |
2010/09/22 | 1,106 | 1,117 | 1,098 | 1,106 | +1 | +0.1% | 117,000 |
2010/09/21 | 1,109 | 1,115 | 1,094 | 1,105 | -4 | -0.4% | 126,000 |
2010/09/17 | 1,112 | 1,124 | 1,109 | 1,109 | +6 | +0.5% | 154,000 |
2010/09/16 | 1,121 | 1,121 | 1,094 | 1,103 | -16 | -1.4% | 149,000 |
2010/09/15 | 1,124 | 1,124 | 1,103 | 1,119 | -5 | -0.4% | 154,000 |
2010/09/14 | 1,101 | 1,128 | 1,101 | 1,124 | +26 | +2.4% | 222,000 |
2010/09/13 | 1,115 | 1,118 | 1,096 | 1,098 | -7 | -0.6% | 104,000 |
2010/09/10 | 1,120 | 1,134 | 1,102 | 1,105 | +7 | +0.6% | 213,000 |
2010/09/09 | 1,099 | 1,099 | 1,085 | 1,098 | +14 | +1.3% | 81,000 |
2010/09/08 | 1,087 | 1,091 | 1,083 | 1,084 | -3 | -0.3% | 155,000 |
2010/09/07 | 1,062 | 1,090 | 1,062 | 1,087 | +10 | +0.9% | 133,000 |
3301~
3350
件表示中 / 3458件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日本新薬 | 369,300円 | +1.2% | -6.3% | 3.36% | 10.15倍 | 1.13倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ツムラ | 395,700円 | +22.6% | +68.1% | 3.44% | 10.54倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
サワイGHD | 610,500円 | +14.2% | +48.9% | 2.60% | 8.91倍 | 1.26倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
ペプチド | 191,500円 | +56.7% | +357.2% | 0.00% | 17.73倍 | 6.15倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
科研薬 | 344,000円 | +4.2% | -21.6% | 4.36% | 23.26倍 | 0.91倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム